Doctor profile · Federal record

Dr. David Barclay, PA-C

Physician Assistant · Meridian, ID

  • NPI 1285803445
  • Accepts Medicare
  • MIPS 100.0 / 100 · 2023
  • 18 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1618 S Millenium Way Ste 100
Meridian, ID 836426457
(208) 884-3376
fax (208) 884-0858

Credentials & registration

NPPES · NUCC
NPI registered
February 2008 — 18 yrs on file
Profile last updated
June 4, 2025
Year of graduation
2008 — 18 yrs since
Specialty taxonomy
363A00000X — NUCC code
State license (1)
Idaho #PA733
Medicaid
ID #807962400

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1285803445. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
2,174
Distinct HCPCS
10
Medicare allowed
$89,079
HCPCS Description Services Patients Avg allowed
17003 Destruction of precancer skin growth, 2-14 growths 971 194 $5
99213 Established patient office or other outpatient visit, 20-29 minutes 414 357 $71
17000 Destruction of precancer skin growth, 1 growth 280 248 $47
11102 Biopsy of related skin growth, first growth 112 105 $79
99203 New patient office or other outpatient visit, 30-44 minutes 92 92 $88
99214 Established patient office or other outpatient visit, 30-39 minutes 78 62 $101
99212 Established patient office or other outpatient visit, 10-19 minutes 68 67 $45
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 41 11 $1
99202 New patient office or other outpatient visit, 15-29 minutes 22 22 $57
12032 Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm 21 19 $227

In context: peer comparison

Among 46 peers in this city , average services per provider: 95. This provider delivers 23× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,632
Transactions
89
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
ABBVIE INC. 26 $814.07
Janssen Biotech, Inc. 6 $380.68
Regeneron Healthcare Solutions, Inc. 11 $267.41
E.R. Squibb & Sons, L.L.C. 2 $240.90
Galderma Laboratories, L.P. 9 $227.97
Novartis Pharmaceuticals Corporation 15 $213.11
Dermavant Sciences, Inc. 8 $208.29
SUN PHARMACEUTICAL INDUSTRIES INC. 3 $62.34
Janssen Scientific Affairs, LLC 1 $42.35
Arcutis Biotherapeutics, Inc. 2 $31.03
UCB, Inc. 2 $30.89
Incyte Corporation 1 $24.26
Lilly USA, LLC 1 $20.94
GENZYME CORPORATION 1 $18.58
Organogenesis Inc. 1 $18.15

By nature of payment

Food and Beverage
$2,523
Education
$108

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
585
Patients
316
Total drug cost
$366,898
Drug Type Claims Patients Total cost
Triamcinolone Acetonide Generic 124 96 $1,232
Ketoconazole Generic 103 64 $2,198
Clobetasol Propionate Generic 62 46 $2,759
Betamethasone Dipropionate Generic 49 38 $3,425
Doxycycline Hyclate Generic 44 18 $1,352
Ciclopirox (Ciclopirox Olamine) Brand 32 22 $1,199
Doxycycline Monohydrate Generic 27 0 $928
Mupirocin Generic 24 21 $214
Humira(Cf) Pen (Adalimumab) Brand 23 0 $289,915
Calcipotriene Generic 19 11 $3,444

Frequently asked questions

Auto-generated from federal data
What is Dr. David Barclay's medical specialty?
Dr. David Barclay practices Physician Assistant in Meridian, ID.
Where does Dr. David Barclay practice?
Dr. David Barclay practices at 1618 S Millenium Way Ste 100, Meridian, ID 836426457. Office phone: 2088843376.
What is Dr. David Barclay's NPI?
Dr. David Barclay's National Provider Identifier (NPI) is 1285803445, issued by NPPES.
Does Dr. David Barclay accept Medicare assignment?
Yes. Dr. David Barclay accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. David Barclay commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.